reports
- Paul de Froment
- Sebastián Marroquin Mérida
- Thomas Mordelle
McPhy: 1MW order from Valorem
Yesterday, McPhy announced that it had won a contract to supply French company Valorem, an integrated renewable IPP, with ~800MW installed multi-energy (solar, wind, hydro) capacity and around 5.7GW under development, with a McLyzer system representing 1MW of electrolyser capacity as well as a hydr
- Emna Ben Bdira
- Maxime Kogge
ArcelorMittal : After Q2 set to be mixed, H2 should see the group’s po...
>After a good Q1, the guidance for Q2 is a bit more mixed - We got an update from the company following its Q1 release. On 2 May ArcelorMittal released good results with top notch activity in North America and good resilience in other divisions despite lacklustre demand and an influx of Asian imports. The group also confirmed its full-year forecasts for steel demand even though it underlined at this stage the lack of restocking at distributors and clients. Following t...
- Emmanuel Matot
Solutions 30 : Début d’année mitigé mais objectifs annuels inchangés
>Faible croissance de l’activité au 1er trimestre - Solutions 30 a publié hier soir son CA au titre du T1 2024. Il ressort en croissance organique de 3% à 265 M€, un niveau en deçà de nos attentes (280 M€) et en ralentissement par rapport à la dynamique de l’année dernière (+17%).Le Benelux reste porteur (+22% à 101 M€ - rythme soutenu des déploiements de la fibre et poursuite du déploiement des compteurs numériques) mais la récession se poursuit en France (-5% ...
Serstech receives 1.9 MSEK order from US partner Field Forensics
Serstech receives 1.9 MSEK order from US partner Field Forensics Serstech has today received an order of approx. 1.9 MSEK from its US partner Field Forensics. The order consists of the newly launched Serstech Arx mkII, the patented SERS kit and ChemDash software. The order will be delivered and invoiced in Q2 2024. For further information, please contact: Stefan Sandor, CEO, Serstech AB Phone: Email: or Thomas Pileby, Chairman of the Board, Serstech AB Phone: Email: or visit: This is information that Serstech AB (publ.) is obliged to make public pursuan...
Kennametal Inc: 2 directors
Two Directors at Kennametal Inc sold/bought 22,000 shares at between 26.000USD and 26.095USD. The significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...
SiTime Corp: 3 directors
Three Directors at SiTime Corp sold 5,314 shares at between 115.420USD and 125.000USD. The significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
- Clement Genelot
Food Retail: Navigating stormy waters of deflation and price war
As food deflation risks increasingly diverge from one market to another, we take a fresh look at local price war risks and at the sector earnings cycle. We remain puzzled by the YTD sector derating and underperformance while FY 2024-25 expected EPS growth is still strong. Many investors seem to be
Ændring til bestyrelsen
Ændring til bestyrelsen Næstformand i Tivoli A/S, Gregers Wedell-Wedellsborg har meddelt Tivoli, at han udtræder af bestyrelsen med virkning fra offentliggørelse af halvårsregnskabet. Dette sker i forbindelse med anden nytilkommen bestyrelsesaktivitet for Gregers Wedell-Wedellsborg. Tivoli takker for samarbejdet og ønsker held og lykke. Med venlig hilsen Tom Knutzen Susanne Mørch KochBestyrelsesformand Adm. direktør Kontaktperson: Pressechef, Torben Plank tlf. 22237440 / Vedhæftet fil ...
Change to the Board of Directors
Change to the Board of Directors Deputy Chairman in Tivoli A/S, Gregers Wedell-Wedellsborg have informed Tivoli, that he is stepping down from the Board of Directors with effect from the publication of the Interim Report for the period 1 January – 30 June 2024. The change is due to other new board activity for Gregers Wedell-Wedellsborg. Tivoli thanks for the cooperation and wishes good luck going forward. Best regards Tom Knutzen Susanne Mørch KochChairman CEO Contact person: Head of press, Torben Plank phone 22237440 / ...
EQS-News: Q3 2023/24: Volatiles Marktumfeld beeinflusst das Ergebnis
EQS-News: Verbio SE / Schlagwort(e): 9-Monatszahlen Q3 2023/24: Volatiles Marktumfeld beeinflusst das Ergebnis 14.05.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Q3 2023/24: Volatiles Marktumfeld beeinflusst das Ergebnis Q3 2023/24 EBITDA liegt unter dem vergleichbaren Vorjahres- und Vorquartal Verbio erwartet deutliche Ergebnisverbesserung in Q4 2023/24 Positive Entwicklung in den Wachstumsprojekten Bundesregierung reagiert auf UER-Betrug aus China Leipzig, 14. Mai 2024 – Trotz Anstieg der Produktions- und Absatz...
EQS-News: Q3 2023/24: Volatile market environment affects earnings
EQS-News: Verbio SE / Key word(s): 9 Month figures Q3 2023/24: Volatile market environment affects earnings 14.05.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Q3 2023/24: Volatile market environment affects earnings Q3 2023/24 EBITDA lower than in the comparable prior-year period and previous quarter Verbio expects significant improvements in earnings in Q4 2023/24 Positive developments in growth projects German Federal Government reacts to fraudulent UERs from China Leipzig, May 14, 2024 – Despite increased production a...
Aecom : 1 director
A director at Aecom sold 7,179 shares at 93.510USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing C...
- Amira Manai
- Aurelien Sivignon
Forsee Power : T1 en phase avec la guidance FY
>Croissance dynamique au T1 - Forsee Power publie ce matin un CA T1 solide avec une progression de 40% y-o-y à 53 M€ (vs 48 M€e). A l’instar de 2023, c’est uniquement le segment des véhicules lourds (89% du CA T1) qui a tiré la croissance avec une hausse de 50% sur le T1 à 47 M€ (vs 40 M€e) alors que le segment des véhicules légers (11% du CA T1) a diminué de 10% à 6 M€, ce qui ne reflète pas vraiment le pipe commercial. Le carnet de commandes fermes pour 2024 s’étab...
- Ana Arjona-Martinez
- Antonio Rodriguez Vicens
HOCHTIEF : Tight results due to Cimic’s margin and with another year o...
>P&L in line with consensus and slightly below our estimates, with higher cash consumption to be recovered later in the year - Hochtief’s Q1 2024 results were in line with the consensus and slightly below our estimates (EBITDA 0.1% below Bloomberg consensus and 5.9% below our estimates), showing contained deviations throughout the P&L but with a slightly weaker margin in Cimic (Asia-Pacific): group revenues € 6,757m (3.5% above css; € 46m or 0.7% below our € 6,803m ...
- Florent Laroche-Joubert
Inmobiliaria Colonial : Q1 2024 – good start to the year with a better...
>Organic rental revenue growth of +6.3% y-o-y in Q1 2024 - Colonial started the year with a solid operating performance in Q1 24 with EPRA EPS of € 8.7 (+25% y-o-y) including rental revenue growth of +6.2% on current scope, driven by very strong operating momentum in Paris, as we detailed a few days ago in our flash on SFL (click here):Rental revenue growth on constant scope came to +6.3% in line with the best office REITs. This includes indexation of +3.2%, a va...
- Ana Arjona-Martinez
- Antonio Rodriguez Vicens
Ferrovial : Strong operating results from the Managed Lanes with a hea...
>P&L a touch ahead of our estimates and consensus - Ferrovial’s Q1 results were a touch ahead of both consensus (EBITDA 7% above despite revenues 1% below) and our estimates (EBITDA 6% above despite revenues 1% below), at the operating level. The outperformance came from the US Managed Lanes (EBITDA € 12m or 6% above our estimates), the most relevant assets for valuation purposes, with the Construction division’s and the Energy Infrastructure & Mobility division’s und...
Moody's Ratings assigns A1 to JFM bonds due May 2034 (Japanese only)
1/4NEWSContact:東京 東京粟野 幸子 セメトコ 真理子主任格付アナリスト／アナリスト 格付責任者／ｱｿｼｴｲﾄ･ﾏﾈｰｼﾞﾝｸﾞ･ﾃﾞｨﾚｸﾀｰサブソブリン・グループ コーポレート・ファイナンス・グループムーディーズ・ジャパン株式会社 ムーディーズ・ジャパン株式会社お客様専用電話番号：03-5408-4100報道関係者電話番号：03-5408-4110お客様専用電話番号：03-5408-4100報道関係者電話番号：03-5408-4110[MJKK]地方公共団体金融機構が発行する債券にA1の格付を付与 2024年5月14日、東京、ムーディーズ・ジャパン株式会社は、以下の格付を付...
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 202...
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024 GUANGZHOU, China, May 14, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that, as previously announced on April 26, 2024, the ratio change of its American depositary shares (the “ADSs”) to Class A ordinary shares from one (1) ADS representing one (1) Class A ordinary share to one (1) ADS representing ten (10) Class A ...
EQS-News: DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT P...
EQS-News: Defence Therapeutics Inc. / Key word(s): Patent DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES 14.05.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES Vancouver, BC, Canada, May 14, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a Canadian biopharmaceutical company developing nov...
EQS-News: CANCOM: CANCOM Gruppe startet mit deutlichem Wachstum in das...
EQS-News: CANCOM SE / Schlagwort(e): Quartals-/Zwischenmitteilung CANCOM: CANCOM Gruppe startet mit deutlichem Wachstum in das Geschäftsjahr 2024 14.05.2024 / 07:59 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CANCOM: CANCOM Gruppe startet mit deutlichem Wachstum in das Geschäftsjahr 2024 Konzern-Umsatz mit deutlichem Plus von 38,7 Prozent auf 440,6 Mio. € verbessert Operativer Cashflow gegenüber Vorjahresquartal um rund 100 Mio. € höher und damit auf historischem Rekordhoch von +56,3 Mio. € im ersten Quartal Vorstand bestätigt ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.